China Resources Medical Holdings Company Limited (1515.HK)
HKD 3.97
(-0.5%)
HKD 3.97
(-0.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.21 Billion CNY | 178.34% |
| 2022 | 965.24 Million CNY | 7.39% |
| 2021 | 527.9 Million CNY | 41.69% |
| 2020 | 372.57 Million CNY | -34.23% |
| 2019 | 566.45 Million CNY | -6.04% |
| 2018 | 602.86 Million CNY | 15.95% |
| 2017 | 519.92 Million CNY | 84.23% |
| 2016 | -1.4 Billion CNY | 27.74% |
| 2015 | 220.92 Million CNY | -10.89% |
| 2014 | 247.91 Million CNY | 44.47% |
| 2013 | 171.6 Million CNY | -13.6% |
| 2012 | 197.79 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 840.13 Million CNY | 0.0% |
| 2023 Q2 | 892.29 Million CNY | 0.0% |
| 2023 FY | - CNY | 178.34% |
| 2023 Q4 | 519.05 Million CNY | 0.0% |
| 2022 Q2 | 445.82 Million CNY | 0.0% |
| 2022 FY | - CNY | 7.39% |
| 2022 Q4 | 436.92 Million CNY | 0.0% |
| 2021 Q2 | 256.92 Million CNY | 0.0% |
| 2021 FY | - CNY | 41.69% |
| 2021 Q4 | 270.98 Million CNY | 0.0% |
| 2020 Q2 | 173.27 Million CNY | 0.0% |
| 2020 Q4 | 199.3 Million CNY | 0.0% |
| 2020 FY | - CNY | -34.23% |
| 2019 Q4 | 303.96 Million CNY | 0.0% |
| 2019 FY | - CNY | -6.04% |
| 2019 Q2 | 262.48 Million CNY | 0.0% |
| 2018 Q4 | 316.14 Million CNY | 0.0% |
| 2018 Q2 | 286.71 Million CNY | 0.0% |
| 2018 FY | - CNY | 15.95% |
| 2017 Q4 | 254.96 Million CNY | 0.0% |
| 2017 FY | - CNY | 84.23% |
| 2017 Q2 | 264.96 Million CNY | 0.0% |
| 2016 Q2 | 141.36 Million CNY | 0.0% |
| 2016 Q4 | 140.84 Million CNY | 0.0% |
| 2016 FY | - CNY | 27.74% |
| 2015 Q2 | 109.61 Million CNY | 0.0% |
| 2015 FY | - CNY | -10.89% |
| 2015 Q4 | 111.3 Million CNY | 0.0% |
| 2014 Q4 | 150.81 Million CNY | 0.0% |
| 2014 FY | - CNY | 44.47% |
| 2014 Q2 | 97.1 Million CNY | 0.0% |
| 2013 FY | - CNY | -13.6% |
| 2013 Q4 | 96.62 Million CNY | 0.0% |
| 2013 Q2 | 74.98 Million CNY | 0.0% |
| 2012 Q1 | 47.03 Million CNY | 0.0% |
| 2012 Q3 | 47.03 Million CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | 52.13 Million CNY | 10.84% |
| 2012 Q2 | 47.03 Million CNY | 0.0% |
| 2011 Q4 | 47.03 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 68.84 Million HKD | -1670.053% |
| UMP Healthcare Holdings Limited | 161.98 Million HKD | -652.334% |
| Human Health Holdings Limited | 104.06 Million HKD | -1071.054% |
| EuroEyes International Eye Clinic Limited | 292.1 Million HKD | -317.196% |
| Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | -812.085% |
| Bamboos Health Care Holdings Limited | 52.75 Million HKD | -2209.879% |
| Beijing Health (Holdings) Limited | -44.19 Million HKD | 2857.679% |
| C-MER Eye Care Holdings Limited | 359.88 Million HKD | -238.624% |
| Town Health International Medical Group Limited | 53.5 Million HKD | -2177.8% |
| Medicskin Holdings Limited | 6.77 Million HKD | -17884.74% |
| Hang Chi Holdings Limited | 81.58 Million HKD | -1393.677% |